Innate Immune System and Inflammation in Alzheimer's Disease: From Pathogenesis to TreatmentSerpente M. · Bonsi R. · Scarpini E. · Galimberti D.
Neurology Unit, Department of Pathophysiology and Transplantation, University of Milan, Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico, Milan, Italy
Immune activation and inflammation, likely triggered by amyloid-beta (Aβ) deposition, play a remarkable role in the pathogenesis of Alzheimer's disease (AD), which is the most frequent cause of dementia in the elderly. The principal cellular elements of the brain innate immune system likely to be involved in such processes are microglia. In an attempt to search for new disease-modifying drugs, the immune system has been addressed, with the aim of removing deposition of Aβ or tau by developing vaccines and humanized monoclonal antibodies. The aim of this review is to summarize the current evidence regarding the role played by microglia and inflammatory molecules in the pathogenesis of AD. In addition, we will discuss the main active and passive immunotherapeutic approaches.
Neurology Unit, Department of Pathophysiology and Transplantation
University of Milan, Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico
Via Francesco Sforza 35, IT-20122 Milan (Italy)
M.S. and R.B. contributed equally to this work.
Published online: February 14, 2014
Number of Print Pages : 9
Number of Figures : 0, Number of Tables : 0, Number of References : 71
Vol. 21, No. 2-3, Year 2014 (Cover Date: February 2014)
Journal Editor: Savino W. (Rio de Janeiro)
ISSN: 1021-7401 (Print), eISSN: 1423-0216 (Online)
For additional information: http://www.karger.com/NIM